Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2363817 | 0.98 | OPRM1 (0.34) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL2363335 | 0.98 | OPRM1 (0.34) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL4411839 | 0.95 | KDM4E (0.33) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL7057032 | 0.93 | KDM4E (0.33) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL2363740 | 0.93 | KDM4E (0.33) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL3806768 | 0.93 | KDM4E (0.33) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL5399561 | 0.93 | KDM4E (0.33) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL2363876 | 0.92 | OPRM1 (0.36) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL3430771 | 0.88 | OPRM1 (0.34) | OPRM1OPRD1OPRK1ALDH1A1TSHR | |
| SCHEMBL2733647 | 0.87 | ALDH1A1 (0.34) | OPRM1OPRD1OPRK1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718564-B2 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-05-18 | — | — | US | claimed |
| US-7605107-B2 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-10-20 | — | — | US | claimed |
| US-7538066-B2 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-05-26 | — | — | US | claimed |
| US-20070082811-A1 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-04-12 | — | — | US | claimed |
| US-20070072765-A1 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-03-29 | — | — | US | claimed |
| EP-2531480-B1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-01-16 | — | — | EP | disclosed |
| US-9035107-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-9024078-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-8969639-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-03-03 | — | — | US | disclosed |
| US-8884075-B2 | Process for producing phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140148620-A1 | Process for Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-20120323046-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-12-20 | — | — | US | disclosed |
| US-20120302798-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-11-29 | — | — | US | disclosed |
| US-20120271077-A1 | Dehydrogenation Process | EXXONMOBILE CHEMICAL PATENTS INC. (US) | 2012-10-25 | — | — | US | disclosed |
| WO-2012050665-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2011096992-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096997-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096994-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| US-7718564-B2 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| US-20060293544-A1 | Partially decomposed catalyst and hydrocarbon oxidation processes using the same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148620-A1 | Process for Producing Phenol | HPD, CYP2J2, CYP2E1 | OPRM1 2691/4885OPRD1 1395/4885OPRK1 1094/4885 |
| US-20120271077-A1 | Dehydrogenation Process | ADH5, ADH1A, ADH1C | OPRM1 1631/4885OPRD1 528/4885OPRK1 1174/4885 |
| US-20120302798-A1 | Dehydrogenation Process | NDUFV1, NDUFV2, MAFG | OPRM1 2532/4885OPRD1 1453/4885OPRK1 1981/4885 |
| US-20120323046-A1 | Dehydrogenation Process | ADH1A, ADH5, ADH1C | OPRM1 1061/4885OPRD1 373/4885OPRK1 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.